Basal transcription of the HIV-1 genome is controlled by a variety of ubiquitous and inducible regulatory factors, some with the ability to associate with the viral DNA sequences within the promoter spanning the long terminal repeat (LTR). In this report we demonstrate that activation of the HIV-1 promoter through the inducible DNA binding NF-kB transcription factors can be affected by cdk9 in human astrocytic cells. Our results show that ectopic expression of cdk9, but not its mutant variant which lacks the domain responsible for its kinase activity, augments transcription of the LTR. Moreover, we demonstrate that induction of the NF-kB pathway by PMA, or overexpression of its subunits including p50/p65 have a negative effect on the ability of cdk9 to stimulate viral gene transcription in these cells. Results from bandshift experiments demonstrated significant suppression of p50/p65 association to its DNA target motif by cdk9. Further, data from GST pull-down and combined immunoprecipitation/Western blot analysis of the protein extracts from cells expressing cdk9, p50 and p65 have revealed the interaction of cdk9 with both p50 and p65 in the absence of DNA containing the kB motif. All of these observations led us to conclude that the interaction of cdk9 with the NF-kB factors can determine the ability of NF-kB to modulate HIV-1 gene transcription.
Transcription of the HIV-1 promoter is regulated by a variety of cellular proteins with the ability to directly or indirectly interact with the DNA sequence (Pereira et al., 2000) . These factors, some with inducible characteristics whose expression and/or activities are augmented by the environmental stimuli, may communicate with each other, either on or off the DNA sequences to exert their regulatory effect upon viral gene transcription. In this respect, a great deal of attention has been focused on the kB DNA motif of HIV-1 which is located between 7117 and 780 of the HIV-1 long terminal repeat, LTR, and its cellular DNA binding proteins, the NF-kB family of transcription factors. The two well-studied members of this family are p50 and p65 whose activity can be induced by a broad range of biological and pharmacological agents including tumor necrosis factor a (TNFa), and phorbol esters such as PMA (Kumar et al., 1996; Beg et al., 1993) . Treatment of the cells with these agents results in degradation of IkB, a cytoplasmic partner of p50/p65 that under unstimulated conditions, retains these subunits in the cytoplasm. In the absence of IkB, both p50 and p65 enter into the nuclei and by associating with their DNA target sequences stimulate transcription of the genes containing the kB motif. Interestingly, infection with a variety of viruses also results in stimulation of the NF-kB regulatory pathway, which in turn, may lead to initiation of viral lytic infection (Arenzana-Seisdedos et al., 1995) . Activation of NF-kB upon viral infection, through stimulation of various cytokines including TNFa, can indirectly affect the severity of the disease by causing various injuries (Rostasy et al., 2000) . Several laboratories have identified a number of cellular and viral proteins that through association with either subunit of NF-kB modulate their transcriptional regulatory ability (Bandres and Ratner, 1994; Hiscott et al., 1997) . For example, the association of p50 and p65 with HTLV-1 Tax may dictate the extent of transcriptional activation of the viral promoter by Tax (Lindholm et al., 1990) . Further, communication between the HIV-1 transcription activator, Tat, and NF-kB subunits plays an important role in the level of viral gene expression in the cells. Tat is an early protein of HIV-1, which through interaction with the TAR RNA sequence located in the leader of the viral transcript, augments transcription initiation and elongation of the viral genome (Berkhout et al., 1989) . According to one model, interaction of Tat with TAR brings p-TEF, which is a component of cyclin T and its catalytic subunit, cdk9, to the vicinity of the transcription initiation complex where cdk9 can phosphorylate the carboxyl terminal domain of the large subunit of RNA polymerase II and potentiate its activity upon viral gene transcription (Price, 2000; Wei et al., 1998) . Furthermore, more recent studies suggested that elongation of RNA polymerase II can be augmented through the interaction of NF-kB and p-TEFb (Barboric et al., 2001) . The ability of Tat to communicate with NF-kB on one hand, and cdk9 on the other, prompted us to investigate the role of cdk9 in transcription of the LTR through its communication with NF-kB. We chose human astrocytic cells since our earlier studies revealed a novel pathway which includes interaction of the NF-kB pathway with Tat in these cells that potentiates the ability of Tat to stimulate viral gene transcription through the kB motif and in the absence of TAR (Taylor et al., 1992 (Taylor et al., , 1994 .
In the first series of experiments, we examined the ability of cdk9 to modulate the basal transcriptional activity of the HIV-1 LTR in the untreated and PMAtreated human astrocytic cell line, U-87MG. As shown in Figure 1 , ecotopic expression of cdk9, but not its kinase deficient mutant, cdk9DN (Foskett et al., 2001; Garriga et al., 1996) , caused an enhancement in the level of LTR transcription in untreated cells (Figure 1a , compare lanes 2 and 3). As anticipated, treatment of the cells with PMA elevated the basal activity of the LTR promoter (compare lanes 1 in Figure 1a ,b) and that the observed induction was diminished by cdk9 (in Figure 1a ,b compare lanes 2) suggesting that PMA treatment has a negative impact upon cdk9 transcriptional activity. As PMA is a known inducer of the NFkB pathway, in follow-up experiments we investigated functional interaction of cdk9 and the p50 and p65 subunits of NF-kB. Results from transfection studies showed that the stimulatory effects of p50, p65, and cdk9 were decreased in cells co-expressing p50 and cdk9 or p65 and cdk9 (Figure 1c , compare lanes 5 and 6 to lane 4). A similar effect was observed in cells treated with PMA ( Figure 1d , compare lanes 5 and 6 to lane 4), again supporting the notion that antagonistic communication between cdk9 and p50 or p65 abrogates their ability to fully up-regulate HIV-1 gene transcription. Of note, co-production of p50 and p65 showed no improvement in the level of transcription suppression in cells expressing cdk9 (data not shown), suggesting that communication of cdk9 with p50 and p65 can occur in the presence of both NF-kB subunits.
In the next experiment we determined whether ectopic expression of cyclin T1, a known partner of cdk9 can affect the observed negative interplay of NFkB and cdk9 upon LTR transcription. Toward this end, cells were transfected with CMV-based plasmids expressing cyclin T1 and cdk9, alone or together, in the absence and presence of PMA-stimulation of NF-kB. As shown in Figure 2 , treatment of the cells with PMA further enhanced the level of LTR activation by cyclin T1 (lane 3). Co-expression of cdk9 and cyclin T1 in PMA treated cells resulted in a reduced level of LTR transcription compared to that of untreated cells (lane 4). This observation suggests that NF-kB factors are able to diminish the activity of cdk9 alone, but not that of cyclin T1/cdk9 on the transcription of the HIV-1 LTR in these cells. The mutant cyclin T1 containing the residues 1 -250, which showed no ability to augment LTR transcription in unstimulated cells had no significant effect on viral promoter activity, alone or together with cdk9, in cells treated with PMA (data not shown).
To examine the importance of the kB motif in the observed regulatory event, a truncated LTR promoter encompassing the sequences between 7117 to +80 was introduced into untreated and PMA-treated U-87MG cells in the presence of cdk9 expressing plasmids. As shown in Figure 3 , treatment of cells with PMA decreased the level of viral transcription, suggesting that the region between 7117 to +80 is important for the functional communication between cdk9 and p50/p65 ( Figure 3 , lane 1). Removal of the TAR region of the LTR between +3 and +80 revealed that expression of cdk9 is able to downregulate PMA-induced activation of the viral promoter in the absence of TAR ( Figure 3 , lane 2). Deletion of the two kB motifs which are the binding sites for p50 and p65 significantly decreased the level of LTR transcription in the untreated and PMA-treated cells and that the levels of transcription in the untreated and PMA-treated cells expressing cdk9 remained comparable with each other (Figure 3 , lane 3). In contrast, 7117/+3 constructs with a deletion in the three GCrich motifs remained responsive to PMA-induced suppression of cdk9-mediated transcription of the viral promoter ( Figure 3 , lane 4). These results demonstrated that the sequence corresponding to the kB motif of the LTR is important for cdk9 and NF-kB communication.
As NF-kB subunits exert their activity through their interaction with the kB DNA sequence, in the next series of experiments we assessed the binding ability of p50 and p65 in the presence of cdk9 protein. Results from band-shift experiments demonstrated that incubation of the 32 P-labeled DNA oligonucleotide containing the kB motif of the LTR with bacterially-produced purified p50 led to the formation of a nucleoprotein complex (Figure 4a ). The addition of bacteriallyproduced cdk9 to the binding reaction completely blocked formation of the kB : p50 complex. This inhibition may not be attributed to the GST-moiety of bacterially-produced GST-cdk9 as incubation of the probe with p50 (shown in Figure 4a , lane 1) was carried out in the presence of GST to normalize the amounts of proteins in each reaction. The absence of an additional complex in lane 2 suggests that cdk9 may not directly bind to the kB DNA probe and/or the kB : p50 complex. Similar experiments were performed with highly purified p65 in the absence and presence of GST -cdk9. As illustrated in Figure 4b , the intensity of the bands corresponding to p65 DNA complex was reduced upon incubation of the binding reaction with GST -cdk9, supporting the notion that cdk9 can diminish the interaction of p65 with the DNA probe. Further, cdk9 was able to drastically decrease the association of p50 : p65 with the kB probe (Figure 4c) . Results from supershift analysis using specific anti-bodies that recognize the NF-kB protein showed the presence of the p50 and p65 proteins in the observed nucleoprotein complex (data not shown). Again, no evidence for the interaction of cdk9 with kB was observed in these studies.
To investigate the effect of cdk9 on the interaction of NF-kB with the kB motif, protein extracts from the unstimulated or PMA-stimulated cells transfected with cdk9 were prepared and mixed with the kB DNA probe. As anticipated, PMA treatment caused an enhancement in the formation of NF-kB protein complexes (Figure 4d, depicted by c) . Transfection of the cells with the cdk9 expression plasmid severely decreased the formation of these complexes in the unstimulated cells (Figure 4d, compare lanes 1 and 3) and noticeably decreased the intensity of the band corresponding to the NF-kB complex in the stimulated cell extract (Figure 4d, compare lanes 2 and 3) . In parallel, interaction of GC-rich binding proteins with the GC-rich DNA motif of HIV-1 was examined and (Foskett et al., 1996; Garriga et al., 1996) by calciumphosphate precipitation (a). In parallel plates, the cells were subjected to PMA-treatment (50 ng/ml) 24 h post transfection to stimulate NF-kB pathway (b). The levels of LTR transcription were measured 48 h post transfection, the cells were harvested and subjected to Luciferase assay. (c) Transfection of U-87 MG with LTR -Luc and pCMV -cdk9 was performed in the absence or presence of 1.0 mg pCMV -p50 or pCMV -p65. All expression plasmids were created in pcDNA3 or pCEP-4-3 background plasmids and empty pcDNA or pCEP-4-3 was included in all transfection mixtures to normalize the amounts of the DNA in each reaction. (d) Transfections were performed as in b except that cells were treated with 50 ng/ml of PMA. The values shown on the top of each bar represent the fold activation over the basal HIV-1 LTR promoter activity which is set at an arbitrarily unit of one. The data represent the mean value of at least three separate transfection experiments, each conducted with various plasmid preparations. In all transfection assays, the final amount of the DNA was kept constant by using empty vector DNA. Further, transfection efficiency was closely monitored by including the plasmid DNA expressing green fluorescent protein, GFP, and the transfected cells were visualized by fluorescent microscopy. In each assay, an equal amount of the proteins were used for Luciferase assay the formation of the complex was used as a control. As shown, while the intensity of the GC-rich associated complexes was slightly increased upon PMA treatment (Figure 4d , compare lanes 1 to 2 and lanes 3 to 4), overexpression of cdk9 showed no effect on the formation of this complex, suggesting that the observed inhibition of NF-kB binding to its DNA motif by cdk9 is not a general event.
The ability of cdk9 to inhibit the association of NFkB proteins with the kB motif without being associated with the DNA probe provided a rationale to investigate the direct interaction of p50 and p65 with cdk9. Thus, we performed GST pull-down assay. First, we investigated the physical interaction of p50 and cdk9 using in vitro translated 35 S-labeled p50 or cdk9 proteins in GST pull-down with GST -cdk9 or GSTp50, respectively. As shown in Figure 5a , a 50 kDa band corresponding to p50 was observed upon elution of the GST -cdk9, but not GST, indicating the ability of p50 to interact with cdk9. In a reciprocal approach, detection of a 38 kDa protein corresponding to cdk9 in eluates from GST -p50, but not GST, verified the direct interaction of p50 and cdk9 in this assay ( Figure  5b) .
A similar strategy was adapted to assess the interaction of p65 with cdk9. As demonstrated in Figure 5c , the presence of a band corresponding to p65 upon elution of GST -cdk9 points to the ability of p65 to associate with cdk9. Again, the reciprocal experiments using in vitro synthesized cdk9 and GST -p65 confirmed the physical association of cdk9 with p65 ( Figure 5d ).
To further investigate the interaction of cdk9 with p50 and p65, PMA-stimulated U-87MG cells were transfected with a plasmid expressing flag-tagged cdk9 and after 48 h, protein extracts were prepared and utilized in immunoprecipitation and Western blot assay. As shown in Figure 5e , incubation of the extract with anti-p50 or anti-p65 antibodies caused precipitation of a complex which upon Western blot analysis using anti-flag antibody showed the presence of cdk9 protein in each complex (Figure 5d, see lanes 3 and 4) . Direct Western blot analysis of the protein extract from the transfected cells showed the expression of flag-tagged cdk9 and the corresponding band served as a control in the gel (Figure 5d, lane 2) . Under similar conditions, this band was absent in the untransfected cells verifying the specificity of this observation, and indicating that cdk9 has the ability to physically interact with p50 and, to a lesser extent, with p65. Thus, one may speculate that interaction of cdk9 with p50/p65 may result in the dissociation of p50/p65 from the kB motif and lead to a decrease in the level of transcriptional activation of the LTR by NF-kB. Indeed, this event has a reciprocal effect upon cdk9 function, as in the presence of p50 or p65, cdk9 loses its ability to fully enhance the activity of the viral promoter.
In this study we show that cdk9, the catalytic subunit of human pTEFb, can stimulate the basal level of viral gene transcription via the kB motif. We also demonstrate that this activation which requires the catalytic unit of cdk9 can be diminished once the NF-kB subunits are overexpressed either by induction with PMA or ectopic expression by plasmids leading to speculation that the intracellular concentrations of cdk9 and the NF-kB subunits are critical for the observed regulatory events. The antagonistic effect of cdk9 and NF-kB was also observed in the presence Figure 2 Regulation of HIV-1 LTR by cdk9 and cyclin T1 upon stimulation of NF-kB in human astroglial cells. U-87MG cells were transfected with LTR-Luc alone or together with CMVcdk9 and/or CMV-cyclin T1. Cells were untreated or treated with PMA (50 ng/ml) for 48 h. Protein extracts were prepared and Luciferase activity was determined. The standard controls such as normalization of the plasmid DNAs with empty vector (pCMV), measuring transfection efficiency by the level of GFP expression and the use of equal amounts of proteins in Luciferase assay were carried out. Each transfection was repeated three times to ensure its reproducibility Figure 3 Importance of kB motif of LTR in cdk9 stimulation of LTR. The human astroglial cell line, U-87 MG, was transfected with 0.5 mg of various LTR deletion constructs as schematized on the left and with 0.25 mg of the cdk9 expression plasmid by calcium -phosphate precipitation. After transfection, cells were untreated or treated with PMA as described in the legend to Figure 1 . The values shown to the right represent the fold activation of cdk9 upon transcription of each deletion promoter construct as measured by the Luciferase assay. The cdk9 expression plasmid was created in pCEP-4-3 background plasmid. The empty pCEP-4-3 plasmid was added in all transfection mixtures, to normalize the amounts of the DNA in each reaction. Luciferase activity was determined 48 h after transfection. The data represent the mean value of three separate transfection experiments. As described in Figure 1 , the transfection efficiency was monitored by the level of GFP expression. Furthermore, equal amounts of protein were utilized in each Luciferase assay. Each transfection was repeated three times to ensure its reproducibility Figure 4 Interaction of p50 and/or p65 with the kB motif in the presence of cdk9. (a -c) Band shift assay was performed by using a 20-bp double-stranded synthetic DNA containing the kB motif of the LTR which was labeled at the 5'-end by 32 P-g-ATP using T4 kinase. Approximately 10 5 c.p.m. DNA probe were incubated with 50 ng of p50 (a), 50 ng of p65 (b), and 50 ng of p50 and p65 (c) in the presence of 500 ng of GST (lane 1) or GST -cdk9 (lane 2). The p50 and p65 were bacterially produced, highly purified proteins that were kindly provided to us by Dr B Wigdhal (Penn State University, Hershey, PA, USA). The total amount of protein in each binding reaction remained constant (550 ng) by adding GST. The brackets depicted by C demonstrate complexes formed upon addition of p50, p65 or both. (d and e) Band shift assay using protein extract (10 mg) from untransfected cells or cells transfected with 15 mg of pCMV -cdk9 (5610 5 cells per 10 cm 2 plate) which were maintained for 48 h after transfection in the absence or presence of PMA. The binding reaction was carried out upon incubation of the 32 P-labeled DNA fragment containing the kB or GCrich sequence of the HIV-1 LTR. The reaction contained 1 mg of the sheared salmon sperm DNA and 1 mg of poly(dI-dC) to prevent non-specific binding to the DNA probes. The positions of the NF-kB and GC-rich binding proteins are depicted by a C. The integrity of the complex was verified by supershift analysis using anti p50 antibodies (not shown). P, points to the position of the probe of the cdk9 partner, cyclin T1. Although ectopic expression of cyclin T1 in the PMA treated cells led to stimulation of LTR transcription, suggesting a cooperativity between cyclin T1 and the NF-kB factors. This observation is consistent with earlier reports indicating that p-TEFb binds to NF-kB and that the interaction between cyclin T1 and RelA augments LTR gene transcription (Barboric et al., 2001) . Our data from transcription assay as well as DNA -protein and protein -protein interaction experiments suggest that cdk9, but not its mutant with no kinase domain, has the ability to associate with the 40 kDa IkBa protein (Sawaya et al., unpublished observations) . While the significance of cdk9 interaction with IkB remains unknown, one may speculate a cytoplasmic role for cdk9 in modulating nuclear import of the NF-kB subunits through the association with IkBa (Sawaya B, study in progress).
The association of cdk9 with cyclin T1 is important for activation of the HIV-1 promoter by the viral transactivator, Tat, through the TAR RNA sequence Zhu et al., 1997) . It is believed that phosphorylation of the carboxy terminal domain of RNA polymerase by cdk9 and cyclin T1 complex which is positioned in close proximity of the transcription start site due to its association with Tat : TAR complex, is the underlying mechanism for Tat activation of the LTR Zhou et al., 1998) . Recent studies have demonstrated that cdk9 can associate with several other regulatory proteins including TRAF (MacLachlan et al., 1998 ), b-myb (De Falco et al., 2000 , ubiquitin (Kiernan et al., 2001) Moreover, several studies have indicated a functional role for cdk9 and cyclin T1 in stimulating other promoters including b-myb (De Falco et al., 2000) and TNFa (Darbinian et al., 2001) . The ability of Tat to stimulate TNFa, a cellular gene which lacks the TAR RNA sequence, suggests that the TAR-independent activation by Tat may utilize several pathways which includes direct interaction of Tat with other regulatory proteins such as Pura (Darbinian et al., 2001; Gallia et al., 1999; Krachmarov et al., 1996) , or indirect contribution by interfering with the communication of NF-kB factors such as p65 with cdk9 as described in this report.
The picture which emerges from these observations suggests that the regulatory events involved in the basal and Tat-induced transcription of the viral and cellular genes are highly complicated and are mediated through the interplay between various cellular proteins such as cdk9, NF-kB, and others. As such, the current models should consider the inclusion of other inducible cellular proteins that by communicating with each other and with Tat mediate TAR-dependent and TARindependent regulation of viral and cellular genes. Indeed, one should also consider the variations in the levels of these inducible proteins that may occur during the course of viral gene expression in response to various external stimuli and phsyiologic conditions.
